The chemical class known as RPF1 Inhibitors encompasses a broad range of molecules characterized by their ability to modulate the action of Ribosome Production Factor 1 (RPF1). RPF1 is considered an integral factor in ribosome biogenesis, a multi-step and tightly controlled process that is crucial for protein synthesis and cellular function. The influence of these inhibitors on RPF1 underscores their importance in cell biology and molecular biology research. A significant proportion of RPF1 inhibitors function by targeting RNA Polymerase I, an enzyme indispensable for the generation of ribosomal RNA (rRNA). Inhibiting this enzyme can disrupt the synthesis of rRNA, which subsequently impacts the assembly of ribosomes, a process where RPF1 is believed to be involved. By doing so, these compounds can modulate the function of RPF1, thereby influencing the cellular machinery for protein synthesis.
Some compounds within this class interfere with the initiation step of protein synthesis. These inhibitors can alter the demand for new ribosomes and thereby modulate the function of RPF1. Another subset of RPF1 inhibitors operate by interfering with the spliceosome, a complex molecular structure that plays a critical role in pre-mRNA processing. By disrupting splicing, these inhibitors can influence the role of RPF1 in ribosome biogenesis. Furthermore, some RPF1 inhibitors can affect the function of RPF1 by disrupting N-linked glycosylation of certain ribosomal proteins. This post-translational modification is essential for the appropriate folding and function of these proteins, and by extension, the assembly of ribosomes. Lastly, a unique group of compounds within this class can influence the function of RPF1 by modulating cellular growth and proliferation pathways. These inhibitors can affect the balance of ribosome production, a process where RPF1 is thought to have a role. In essence, RPF1 inhibitors represent a heterogeneous class of compounds that can modulate the function of RPF1, thereby influencing ribosome biogenesis and protein synthesis in cells. While the mechanisms of action can vary across individual compounds, they all share the potential to interfere with the role of RPF1 in the production of ribosomes. This makes them valuable tools in the study of cellular processes and molecular mechanisms.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may potentially inhibit RPF1's function by disrupting rRNA synthesis, which is crucial to the assembly of ribosomes. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Homoharringtonine can interrupt the initiation step of protein synthesis, potentially affecting the demand for new ribosomes and RPF1 function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Pladienolide B may potentially inhibit the role of RPF1 in ribosome biogenesis by affecting rRNA processing. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin may potentially inhibit RPF1's function by disrupting N-linked glycosylation of some ribosomal proteins and consequently the assembly of ribosomes. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid may potentially inhibit RPF1 function by depleting GTP levels, crucial for rRNA synthesis and ribosome biogenesis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Fluorouracil may potentially inhibit RPF1 function by reducing DNA and RNA synthesis, thus impacting ribosome biogenesis. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Amatinib may potentially inhibit RPF1's function by affecting cell growth and proliferation through its inhibition of Bcr-Abl tyrosine-kinase. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
Ibrutinib may potentially inhibit RPF1 function by affecting B-cell development due to its inhibition of Bruton's tyrosine kinase (BTK). | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus may potentially inhibit RPF1 function by affecting cell growth and proliferation through its inhibition of mTOR. | ||||||
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
Zactima may potentially inhibit RPF1 function by affecting cell growth and proliferation through its inhibition of several tyrosine kinases. |